Safety and dose modification for patients receiving niraparib
Ann Oncol
.
2019 May 1;30(5):859.
doi: 10.1093/annonc/mdy255.
Authors
J S Berek
,
U A Matulonis
,
U Peen
,
P Ghatage
,
S Mahner
,
A Redondo
,
A Lesoin
,
N Colombo
,
I Vergote
,
O Rosengarten
,
J Ledermann
,
M Pineda
,
S Ellard
,
J Sehouli
,
A Gonzalez-Martin
,
D Berton-Rigaud
,
R Madry
,
A Reinthaller
,
S Hazard
,
W Guo
,
M R Mirza
PMID:
30107447
DOI:
10.1093/annonc/mdy255
No abstract available
Publication types
Published Erratum